Antizol (PALADIN LABORATORIES (USA) INC)


Welcome to the PulseAid listing for the Antizol drug offered from PALADIN LABORATORIES (USA) INC. This Antidote [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: PALADIN LABORATORIES (USA) INC
NON-PROPRIETARY NAME: fomepizole
SUBSTANCE NAME: FOMEPIZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antidote [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-07-31
END MARKETING DATE: 0000-00-00


Antizol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAntizol from PALADIN LABORATORIES (USA) INC
LABELER NAME: PALADIN LABORATORIES (USA) INC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/mL)
START MARKETING DATE: 2009-07-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 46129-200_c045b5a8-b220-4f0a-a831-155b29c19454
PRODUCT NDC: 46129-200
APPLICATION NUMBER: NDA020696

Other FOMEPIZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Institutional LLCFomepizole
PALADIN LABORATORIES (USA) INCAntizol
Sandoz Inc.fomepizole
X-GEN Pharmaceuticalsfomepizole